$20.00

i 0.50 Hours

Course Overview

Von Willebrand disease (vWD) is the most common inherited genetic bleeding disorder, yet it is not well known or understood among the public or healthcare providers. Von Willebrand factor (vWF) is a protein that is essential for platelet aggregation and clotting. A low vWF can lead to heavy or prolonged bleeding. This most commonly appears as complaints of menorrhagia (i.e., heavy menstrual bleeding), prolonged bleeding after minor injuries, or gum bleeding. The clinician can advocate for proper diagnosis and treatment, as well as prevent adverse events by being aware of the presenting signs and types of the disorder, recognizing that many patients are asymptomatic, and understanding when a hematology consultation is warranted.

About the Course Author

Catherine Swift, MT(ASCP) is the clinical laboratory science editor for Relias Learning. She has a Bachelor of Arts in English from Hastings College and a Bachelor of Science in Medical Technology from North Colorado Medical Center. She has experience working in hospital laboratories, clinic laboratories, and research experience in microbiology as well as clinical research trials involving patients and various drug therapies for osteoporosis, endometriosis and bone density at Creighton University School of Medicine. Catherine J. Swift, MT(ASCP) has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.
Dr. Reist is an Associate Professor (with tenure) in the Department of Psychiatry and Human Behavior at the University of California, Irvine. He also serves as Assistant Dean in the College of Medicine and the Director of Medical Research for the Long Beach Veterans Affairs Healthcare System. Formerly, he served as Chief of Mental Health, overseeing full service mental health care delivery to over 40,000 enrollees at the Long Beach VA Healthcare System. For the past 12 years, he has served as Associate Director of the Southern California VA Mental Illness Research, Education, and Clinical Center (MIRECC), which is focused on improving long-term outcomes in chronic psychotic disorders through basic/clinical research and dissemination of evidence-based practices. Dr. Reist’s clinical interests include schizophrenia, impulsivity, PTSD, pharmacogenomics, and psychopharmacology. NARSAD, NIMH, and VA Medical Research have supported his research. He has served as principal investigator on over 25 clinical trials in areas including schizophrenia, depression, bipolar disorder and impulsivity. He is a member of professional societies, including the American Psychiatric Association, Pacific Rim Association for Clinical Pharmacogenetics, and the Society of Biological Psychiatry. He is a Distinguished Fellow of the Psychiatric Association, has been recognized as an Exemplary Psychiatrist by the National Alliance for the Mentally Ill, and is included in Best Doctors 2007-2010. He is the author of two books, Psychiatry and Psychiatric Drugs, which have been widely used by trainees for the past 15 years. He has over 50 scientific articles that have been published in high-impact journals, including Molecular Psychiatry, Biological Psychiatry, Journal of Clinical Psychiatry, American Journal of Psychiatry, and Nature Biotechnology. Lastly, he has extensive experience in psychiatric education that include organizing CME conferences and developing web content that provide information on psychiatric disorders and treatment. Christopher Reist, MD, MBA discloses the following potential conflict of interests/commercial interests with: Relevant Financial Relationship with Alkermes as Grant/Research Support.

Nicole Strickland, BA, BSN, RN, CPAN has cared for medical-surgical, stepdown, and ICU-level neurology and post-anesthesia care patients. She holds a BA in English from Temple University and worked as a medical editor for the National Board of Medical Examiners before returning to school to obtain a BSN from Duke University. She has devoted much of her nursing career to training nurses and nursing students as a Certified PeriAnesthesia Nurse (CPAN). She now continues her passion for nursing research and education as an acute care SME writer for Relias.

Nicole Strickland, BA, BSN, RN, CPAN has declared that no conflict of interest, Relevant Financial Relationship or Relevant Non-Financial Relationship exists.

Get started now and your first course is free!

CE-PRO Membership
Become a member today and enjoy instant savings on all courses
$19.95 / year

CE-PRO is a membership program that gives you 50% OFF everything you buy and much more.

CE-PRO Membership Benefits

50% Discount on All Course Purchases

Free CE Alerts

Detailed Transcripts

License Tracking/Reminders

Accreditation Information

Certificates provided by accrediting body (11 Match)

  • American Nurses Credentialing Center

    0.50HOURS

    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


  • District of Columbia Board of Nursing

    0.50HOURS

    District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290). Nurses will receive 0.5 contact hours for participating in this course.
  • Georgia Board of Nursing

    0.50HOURS

    Georgia Board of Nursing (CEBroker Provider #50-290). Nurses will receive 0.5 contact hours for participating in this course.
  • Accreditation Council for Continuing Medical Education

    0.50HOURS

    In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


    Relias LLC designates this enduring activity for a maximum of 0.5 AMA PRA category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • South Carolina Board of Nursing

    0.50HOURS

    This program was approved by the South Carolina Board of Nursing Approved Continuing Education Program (CEBroker Provider #50-290).
    Nurses will receive 0.5 contact hours for participating in this course.
  • Florida Board of Medicine

    0.50HOURS

    Florida Board of Medicine (CEBroker Provider #50-290).
  • New Mexico Board of Nursing

    0.50HOURS

    New Mexico Board of Nursing (CEBroker Provider #50-290).
    Nurses will receive 0.5 contact hours for participating in this course.
  • Arkansas State Board of Nursing

    0.50HOURS

    Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
    Nurses will receive 0.5 contact hours for participating in this course.
  • Ohio State Medical Board

    0.50HOURS

    State Medical Board of Ohio (CEBroker Provider #: 50-290)
  • Louisiana State Board of Medical Examiners

    0.50HOURS

    Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
  • Mississippi State Board of Medical Licensure

    0.50HOURS

    Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)


Course Details
  • Course Code:

    REL-ACU-0-VWDIBD
  • Hours:

    0.50
  • Type:

    Online Course
  • Release Date:

    2021-05-01
  • Expiration Date:

    2024-04-30
  • Learning Objectives:

    Describe the diagnostic process, laboratory tests, treatments, and the educational needs of patients with vWD.; Identify clinical manifestations and information from patients’ health histories that suggest vWD.
  • Outline:

    Section 1: Introduction
    About This Course
    Learning Objectives
    Section 2: Understanding von Willebrand Disease
    Overview
    Hemostasis and von Willebrand Factor
    The Profile
    Clinical Work-Up
    Quality-of-Life Issues
    vWD Treatments
    Educational Needs
    Section 3: Clinical Vignette
    Section 4: Conclusion
    Course Summary
    Course Contributor(s)
    Resources
    References
  • Target Audience:

    The target audience for this course is: Clinical Laboratory Personnel; Nurses; Physicians; in the following settings: Acute Care Facility.
  • Course Delivery Method and Format:

    Asynchronous/Online Distance Learning; please see certificate details for specifics on delivery format.
    Relias has a grievance policy in place to facilitate reports of dissatisfaction. Relias will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias.
    If you require special accommodations to complete this module, please contact Relias Support by completing the web form (https://www.relias.com/help) or by using the chat functionality.
    All courses offered by Relias, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
    Reference herein to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer or otherwise does not constitute or imply any endorsement, recommendation, or favoring of, or affiliation with, Relias, LLC.
    All characteristics and organizations referenced in the following training are fictional. Any resemblance to any actual organizations or persons living or dead, is purely coincidental.
    To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
  • Accommodations:

    If you require special accommodations to complete this module, please contact Relias Customer Support here.
  • Disclosures:

    Expert Reviewers, Instructors, and Staff Writers disclosures will be listed above after the individuals' biographical paragraph. All other members involved within the planning of this educational activity have declared no conflict of interest exists when planning and developing this course.